Stage IIA Prostate Cancer Completed Phase 2 Trials for Sargramostim (DB00020)

IndicationStatusPhase
DBCOND0028878 (Stage IIA Prostate Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00108732A Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate CancerTreatment